HSD and The Röchling Group have been invited to attend the 10th annual European Paediatric Formulation Initiative in partnership with International Association for Pharmaceutical Technology for its work with Sympfiny® a next-generation multiparticulate delivery system. Sympfiny® is an innovative system for dosing and dispensing multiparticulate, dry powder, and microsphere drug formulations for oral delivery.

For more information regarding the conference click here.

For more information regarding Sympfiny® click here.